October Strategy: GSK

GSK reported good Q3 results but priced dropped so I bought some more. At this price GSK, I am in regular accumulation mode for GSK.

Currently hold about S$20k+ worth, would like to at least double the holding.

GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER Total EPS 24.8p, +49% AER, +46% CER; Adjusted EPS 32.5p, +3% AER, flat CER

http://www.gsk.com/media/4171/q3-2017-results-announcement.pdf

__________

In other portfolio news, topped up my Euro Stoxx 50 ETF, and WPP

Dividend Report: Sep 2017

Quiet month for dividends. Telstra (TLS) declared dividends this month. Maybe in time to come I will increase my holdings in TLS.




Average dividends per month: Jan- Sep 2017

S$4,102.56  [2016: $3655.43]

£229.44       [2016:£146.99]

US$465.53    [2016: US$169.21]

Average dividends per month: Jan- August2017

S$4,408.59  [2016: $3855.75]
£242.11          [2016:£148.14 ]
US$473.95    [2016: US$170.55]

(also small amount of A$ from IOZ and TLS, will just report at end of the year)











Notes:

Average dividend per month = total dividend collected / number of months in the year so far.+ and - are used to indicate whether the average monthly dividend has gone up or gone down.Vanguard quarterly dividends reported on Jan/April/Jul/Oct